(Q45119911)

English

Transfection of human hepatocyte growth factor gene inhibits advancing pulmonary arterial hypertension induced by shunt flow in a rabbit model

scientific article published in March 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Transfection of human hepatocyte growth factor gene inhibits advancing pulmonary arterial hypertension induced by shunt flow in a rabbit model (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

R Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

S Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

G Cao

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

W Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

K Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

S Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

705-712

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Molecular cloning and expression of human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Emerging concepts and translational priorities in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Bosentan and overcirculation-induced experimental pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Disruption of endothelial-cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Adipose-derived stromal cell autologous transplantation ameliorates pulmonary arterial hypertension induced by shunt flow in rat models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.158

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2012.07.158

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45119911&oldid=2066425514"